| Name | Title | Contact Details |
|---|
Incapital was founded in 1999 with the mission of providing securities firms and individual investors more efficient access to corporate bonds. While Incapital`s expertise in underwriting and distributing investment-grade corporate bonds remains a core competency, the firm now originates and distributes offerings across multiple asset classes. In addition to its broker-dealer and bank partners, Incapital now serves institutional investors and wealth managers. With over 150 employees in multiple offices in North America, the firm represents over 400 issuing entities and serves 800+ distribution partners. Incapital continues to provide market leadership with a growing range of product offerings, strong strategic partnerships and innovative technology.
Palisades Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palisades Medical Center is based in North Bergen, NJ. You can find more information on Palisades Medical Center at www.palisadesmedical.org
A&M Biomedical is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.
Phil is a B2B2C platform that connects patients, pharmacies, prescribers, and manufacturers in the specialty prescription ecosystem. We build software solutions & end-to-end services to power the $320B industry.